All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

1,268

Reset

1,268 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • OnvansertibPhase 22 trials

    Cardiff Oncology · Metastatic Colorectal Cancer, CRC, KRAS/NRAS Mutation

  • Suzhou BlueHorse Therapeutics Co., Ltd. · Non-Small Cell Lung Cancer, Advanced Malignant Solid Tumor

  • Seqker Biosciences, Inc. · Solid Tumors, Advanced Cancer, Recurrent Cancer

  • PF-07104091ovarian, SCLCPhase 22 trials

    Pfizer · Breast Cancer, Solid Tumors, Small Cell Lung Cancer

  • PM54Phase 22 trials

    PharmaMar · Advanced Solid Tumor, Advanced Malignancies

  • QHL-1618ALK-N001Phase 22 trials

    Zhejiang Anglikang Pharmaceutical Co., Ltd. · Advanced Gastrointestinal Tumors, Advanced Solid Tumors

  • QLC1401Phase 22 trials

    Qilu Pharmaceutical Co., Ltd. · Advanced Breast Cancer, Advanced ER+/HER2- Breast Cancer

  • QLH12016Phase 22 trials

    Qilu Pharmaceutical Co., Ltd. · Prostatic Neoplasms, Advanced Prostate Cancer

  • quaratusugene ozeplasmidREQORSAPhase 22 trials

    Genprex, Inc. · Carcinoma, Non-Small Cell Lung, Small Cell Lung Cancer Extensive Stage

  • QuavonlimabMK-1308Phase 22 trials

    Merck & Co. · Melanoma, Advanced Non-Small Cell Lung Cancer

  • RadspherinPhase 22 trials

    Oncoinvent Solutions AS · Peritoneal Carcinomatosis, Ovarian Cancer, Peritoneal Carcinoma

  • RAPA-201 Rapamycin Resistant T CellsRAPA-201 cellsPhase 22 trials

    Rapa Therapeutics LLC · Malignant Melanoma, Malignant Melanoma With Metastasis, Malignant Melanoma Stage IIIc

  • RBS2418Phase 22 trials

    Riboscience, LLC. · Metastatic Colorectal Cancer, Advanced Colorectal Cancer, Advanced Unresectable Hepatocellular Carcinoma

  • RC108Phase 22 trials

    RemeGen Co., Ltd. · Non-Small Cell Lung Cancer, Digestive Cancer

  • RDEABSK141-Recommended Expansion, S095018 RecommendedPhase 22 trials

    Abbisko Therapeutics Co, Ltd · Solid Tumors, Adult, Non-small Cell Lung Cancer (NSCLC)

  • REGN4336Phase 22 trials

    Regeneron · Metastatic Castration-resistant Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Clear Cell Renal Cell Carcinoma (ccRCC)

  • rhuGM-CSFGranulocyte-Macrophage Colony-Stimulating FactorPhase 22 trials

    Aston Sci. Inc. · Gastric Cancer, Advanced Ovarian Cancer

  • S095029Phase 22 trials

    Servier Bio-Innovation LLC · Non-small Cell Lung Cancer (NSCLC), MSI-H/dMMR Gastroesophageal-junction Cancer, MSI-H/dMMR Gastric Cancer

  • SapanisertibFTH-003, MLN0128Phase 22 trials

    Faeth Therapeutics · Endometrial Cancer, HR+ HER2- Breast Cancer

  • SAR445877Phase 22 trials

    Sanofi · Solid Tumor, Gastric Cancer, Oesophageal Carcinoma

  • SCTB39-1Phase 22 trials

    Sinocelltech Ltd. · Advanced Malignant Solid Tumor

  • SCTB39GPhase 22 trials

    Sinocelltech Ltd. · Advanced Malignant Solid Tumor, Advanced Malignant Solid Tumors

  • SelicrelumabPhase 22 trials

    Roche (Genentech) · Metastatic Breast Cancer, Pancreatic Adenocarcinoma

  • SerabelisibFTH-001, MLN1117Phase 22 trials

    Faeth Therapeutics · Endometrial Cancer, HR+ HER2- Breast Cancer

  • SHR-4375Phase 22 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced Solid Tumor, Solid Tumors

  • SHR-4849Phase 22 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Malignant Solid Tumors

  • silevertinibBDTX-1535Phase 22 trials

    Black Diamond Therapeutics, Inc. · Glioblastoma (GBM), Newly Diagnosed Glioblastoma, GBM

  • SKB103Phase 22 trials

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Advanced Solid Tumors, Breast Cancer

  • SKB500Phase 22 trials

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Esophageal Squamous Cell Carcinoma, Small Cell Lung Cancer

  • SKB518Phase 22 trials

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Advanced Gynecological Malignancies, Lung Carcinoma

  • SPGL008Phase 22 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · NMIBC, Non Small Cell Lung Cancer

  • SSGJ-612HER2-targeted antibodyPhase 22 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · Locally Advanced (Unresectable) or Metastatic Solid Tumors, Metastatic Breast Cancer

  • SSGJ-705Phase 22 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · Locally Advanced, Recurrent or Metastatic Malignancies, Locally Advanced (Unresectable) or Metastatic Solid Tumors

  • STAR0602InvikafuspPhase 22 trials

    Marengo Therapeutics, Inc. · Triple Negative Locally Advanced Non-resectable Breast Cancer, HR+, HER2-, Advanced Breast Cancer, Advanced Solid Tumors

  • Sutetinib MaleatePhase 22 trials

    Teligene US · Non-small Cell Lung Cancer

  • SYH2051Phase 22 trials

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Advanced Solid Tumors, Breast Cancer

  • SYS6041Phase 22 trials

    CSPC Megalith Biopharmaceutical Co.,Ltd. · Ovarian Cancer, Recurrent Ovarian Cancer, Advanced Solid Tumors

  • TCC1727Phase 22 trials

    Beijing Tide Pharmaceutical Co., Ltd · Patients with Advanced Solid Tumors, Solid Cancers, NSCLC (Advanced Non-small Cell Lung Cancer)

  • Tigilanol TiglateEBC-46Phase 22 trials

    QBiotics Group Limited · Soft Tissue Sarcoma, Head and Neck Cancer

  • TNO155Phase 22 trials

    Novartis · Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer, Advanced Solid Tumors Harboring the KRAS G12C Mutation, KRAS G12C Mutant Solid Tumors

  • TQB2916Phase 22 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Soft Tissue Sarcoma, Melanoma, Pancreatic Cancer

  • TQB6411Phase 22 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Advanced Lung Cancer, Esophageal Cancer

  • TRK-950Phase 22 trials

    Toray Industries, Inc · Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

  • TST001Phase 22 trials

    Transcenta Therapeutics (Hangzhou) Co., Ltd. · Advanced Cancer, Gastric Cancer, Gastroesophageal-junction Cancer

  • TTI-101Phase 22 trials

    Tvardi Therapeutics, Incorporated · Hepatocellular Carcinoma, Idiopathic Pulmonary Fibrosis

  • TU2218Phase 22 trials

    TiumBio Co., Ltd. · Advanced Solid Tumor, Solid Tumor, Biliary Tract Cancer

  • TYK-00540Phase 22 trials

    TYK Medicines, Inc · mCRPC, HR-positive, HER2-negative Advanced Breast Cancer

  • VEGF antibodyPhase 22 trials

    Lepu Biopharma Co., Ltd. · Hepatocellular Carcinoma, Advanced Colorectal Cancer

  • VG2025Phase 22 trials

    Virogin Biotech Ltd. · Intrahepatic Cholangiocarcinoma, Colorectal Cancer With Hepatic Metastases

  • VortosiranPhase 22 trials

    Ribocure Pharmaceuticals AB · Venous Thromboembolism (VTE), Cancer, Pulmonary Embolism (Diagnosis)

NewerPage 13 of 26Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.